Ann: Preliminary Final Report, page-64

Fillerina is a product manufactured and marketed by a Swiss Registered company called LABO Cosprophar. The same company manufactures and markets Crescina, a hair growth product like Evolis and another face treatment product called Lato Transdemic. The company has a presence in over 32 countries in Europe, USA, Middle East and North Africa. The markets are aggressively marketed via its Italian branch.
If a customer has bought Fillerina and is pretty satisfied and now wants a hair growth product, do you think he/she will go for Evolis or Crescina? The chances are he/she will go for the product from the company he/she has confidence with and that will be Crescina.
By distributing Fillerina, are we not helping our competitor take away our market share of Evolis? Just a thought.